Indexed in Journament

The Journal of investigative dermatology

ISSN 1523-1747· EN

Login or register to claim ownership or editorship of this journal.
40.0/100
Journament Score
#7,485
Journament Rank
132
Articles Indexed

About This Journal

Short Name J Invest Dermatol
Abbreviated Name j invest dermatol
ISSN 1523-1747
URL https://www.sciencedirect.com/journal/journal-of-investigative-dermatology

Indexings

ncbi

Tools & Certificate of Indexing

Certificate of Indexing
Quality Badge Widget - Embed on Your Website

Display your journal's verified indexing scores on your website with our self-contained widget.

One-Line JavaScript Embed:
Advantages: Single-line script, seamless DOM integration, clickable badges linking to full journal profile.
Standard iFrame Embed Code:
Widget Preview:

Publications Per Year

Articles (132)

2012
automated quantitative analysis of p53, cyclin d1, ki67 and perk expression in breast carcinoma does not differ from expert pathologist scoring and correlates with clinico-pathological characteristics
Vol. 4 , No. 3 , pp. 725-742
436 views DOI Abstract
2018
targeting pancreatic cancer cell plasticity: the latest in therapeutics
Vol. 10 , No. 1 , pp. 14-
412 views DOI Abstract
2018
towards a clinical decision support system for external beam radiation oncology prostate cancer patients: proton vs. photon radiotherapy? a radiobiological study of robustness and stability
Vol. 10 , No. 2 , pp. 55-
411 views DOI Abstract
2015
2018
pharmacokinetics of sublingually delivered fentanyl in head and neck cancer patients treated with curatively aimed chemo or bioradiotherapy
Vol. 10 , No. 11 , pp. 445-
371 views DOI Abstract
2011
gold nanostructures as a platform for combinational therapy in future cancer therapeutics
Vol. 3 , No. 1 , pp. 1081-1110
370 views DOI Abstract
2013
immune-checkpoint blockade and active immunotherapy for glioma
Vol. 5 , No. 4 , pp. 1379-1412
369 views DOI Abstract
2018
signal-targeted therapies and resistance mechanisms in pancreatic cancer: future developments reside in proteomics
Vol. 10 , No. 6 , pp. 174-
365 views DOI Abstract
2010
the evolution of biomarkers in thyroid cancer—from mass screening to a personalized biosignature
Vol. 2 , No. 2 , pp. 885-912
346 views DOI Abstract
2020
pembrolizumab activity in recurrent high-grade gliomas with partial or complete loss of mismatch repair protein expression: a monocentric, observational and prospective pilot study
Vol. 12 , No. 2283 , pp. 2283-
343 views DOI Abstract
2020
Multiclass artificial intelligence in dermatology - progress but still room for improvement.
238 views DOI
2020
herc ubiquitin ligases in cancer
Vol. 12 , No. 1653 , pp. 1653-
270 views DOI Abstract
2020
the non-coding rna landscape of plasma cell dyscrasias
Vol. 12 , No. 2 , pp. 320-
277 views DOI Abstract
2020
phenethyl isothiocyanate suppresses stemness in the chemo- and radio-resistant triple-negative breast cancer cell line mda-mb-231/ir via downregulation of metadherin
Vol. 12 , No. 2 , pp. 268-
299 views DOI Abstract
2020
solving the time- and frequency-multiplexed problem of constrained radiofrequency induced hyperthermia
Vol. 12 , No. 1072 , pp. 1072-
242 views DOI Abstract
2020
the rna-binding ubiquitin ligase mex3a affects glioblastoma tumorigenesis by inducing ubiquitylation and degradation of rig-i
Vol. 12 , No. 2 , pp. 321-
258 views DOI Abstract
2020
identification of two kinase inhibitors with synergistic toxicity with low-dose hydrogen peroxide in colorectal cancer cells in vitro
Vol. 12 , No. 1 , pp. 122-
262 views DOI Abstract
2020
pembrolizumab activity in recurrent high-grade gliomas with partial or complete loss of mismatch repair protein expression: a monocentric, observational and prospective pilot study
Vol. 12 , No. 2283 , pp. 2283-
343 views DOI Abstract
2020
overcoming heterogeneity of antigen expression for effective car t cell targeting of cancers
Vol. 12 , No. 1075 , pp. 1075-
138 views DOI Abstract
2020
erratum: benelli, r., et al. aspartate-β-hydroxylase: a promising target to limit the local invasiveness of colorectal cancer. <i>cancers</i> <b>2020</b>, <i>12</i>, 971
Vol. 12 , No. 1226 , pp. 1226-
147 views DOI Abstract
40
Overall
Below Average
31
15
30
40
35
50
0
0
0
0
0

Overall Quality Score

40.0/100

Tier: Below Average

The Journament Overall Quality Score is a comprehensive metric that evaluates academic journals across multiple dimensions including engagement, accessibility, diversity, innovation, and community impact.

This score helps researchers, institutions, and publishers understand the holistic quality and impact of a journal beyond traditional metrics.

Engagement Score

30.7/100

Measures user interactions, views, citations, and community involvement with this journal's content.

Higher engagement scores indicate that the journal's content is actively being read, cited, and discussed within the academic community.

Accessibility Score

15.0/100

Evaluates how easily researchers can access journal content, including open access availability, ISSN registration, and indexing.

This metric considers factors such as paywalls, open access policies, and availability across different academic databases and search engines.

Diversity Score

30.0/100

Assesses geographic and institutional diversity of authors, editorial board composition, and topic breadth.

A diverse journal publishes work from various geographic regions, institutions, and covers a broad range of topics within its field.

Innovation Score

40.0/100

Evaluates research novelty, interdisciplinary work, and emerging topics based on AI analysis of article abstracts.

This score reflects how much the journal publishes cutting-edge research, explores new methodologies, and bridges different academic disciplines.

Community Impact Score

34.5/100

Measures scholarly contribution and real-world applications of published research.

This metric evaluates how the journal's research translates into practical applications, policy changes, and benefits to society beyond academia.

Timeliness Score

50.0/100

Evaluates recent publication activity, publication frequency, and currency of research topics.

Higher scores indicate consistent publishing schedules and timely coverage of current research trends.

Ethics & Transparency Score

0.0/100

Research Integrity (10% weight)

Assesses COPE standards compliance, ethical considerations in research, transparency in methodologies, and reproducibility practices.

This metric ensures the journal maintains high ethical standards and promotes transparent, trustworthy research.

Content Quality Score

0.0/100

Academic Rigor (20% weight) + Methodology Quality (12%)

Evaluates research methodology soundness, statistical rigor, theoretical framework strength, appropriateness of research methods, data quality, and clarity & readability.

This comprehensive metric ensures published research meets the highest academic standards.

Editorial Diversity Score

0.0/100

Author Diversity + Interdisciplinary Value (8%)

Measures geographic diversity of authors, institutional variety, editorial board composition, and cross-disciplinary connections.

Diverse editorial teams bring varied perspectives and reduce bias in academic publishing.

Publication Regularity Score

0.0/100

Assesses consistency of publication schedule, frequency stability, and predictable output patterns.

Regular publication schedules indicate reliable journal operations and consistent workflow management.

Geographic Reach Score

0.0/100

Evaluates international author representation, global readership distribution, and cross-border research collaboration.

Wide geographic reach indicates global impact and international recognition of the journal's research.